AN
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Hydroxyl Ketone-Based Histone Deacetylase Inhibitors To Gain Insight into Class I HDAC Selectivity versus That of HDAC6 | ACS Omega |  | 2017 | 350 | 217 | ||
| Prediction of retention time in reversed-phase liquid chromatography as a tool for steroid identification | Analytica chimica acta |  | 2016 | 567 | 1 | ||
| Synthesis of a selective HDAC6 inhibitor active in neuroblasts | Bioorganic & medicinal chemistry letters | | 2016 | 365 | 0 | ||
| Cross metathesis with hydroxamate and benzamide BOC-protected alkenes to access HDAC inhibitors and their biological evaluation highlighted intrinsic activity of BOC-protected dihydroxamates | Bioorganic & medicinal chemistry letters | | 2016 | 470 | 0 | ||
| Biphenyl-4-yl-acrylohydroxamic acids: Identification of a novel indolyl-substituted HDAC inhibitor with antitumor activity | European journal of medicinal chemistry | | 2016 | 417 | 1 | ||
| Investigation on the ZBG-functionality of phenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase inhibitors | Bioorganic & medicinal chemistry letters | | 2015 | 468 | 0 | ||
| Computational Studies on Sirtuins from Trypanosoma cruzi: Structures, Conformations and Interactions with Phytochemicals | PLoS neglected tropical diseases | | 2014 | 616 | 262 | ||
| Aurones as histone deacetylase inhibitors: identification of key features | Bioorganic & medicinal chemistry letters | | 2014 | 476 | 2 | ||
| HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs? | Molecular neurodegeneration | | 2013 | 639 | 382 | ||
| Unsymmetrical binding modes of HOPNO inhibitor of tyrosinase: From model complexes to the enzyme | Chemistry | | 2013 | 823 | 1 | ||
| Role of N-Glycosylation sites and CXC motifs in trafficking of Medicago truncatula Nod factor perception protein to plasma membrane | The Journal of biological chemistry | | 2012 | 501 | 0 |
